<DOC>
	<DOCNO>NCT01339299</DOCNO>
	<brief_summary>The study prospective , randomise , control , non-blinded multi-center pilot study evaluate endocrine efficacy recombinant luteinizing hormone versus recombinant human chorionic gonadotropin administer controlled ovarian stimulation IVF/ICSI normogonadotrophic woman .</brief_summary>
	<brief_title>Study Examine Effect Recombinant Luteinizing Hormone ( r-Lh ) Recombinant Human Chorionic Gonadotropin ( r-hCG ) Ovarian Stimulation Assisted Reproduction Techniques ( ART )</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Follicle Stimulating Hormone</mesh_term>
	<mesh_term>Chorionic Gonadotropin</mesh_term>
	<criteria>Women plan undergo IVF ICSI treatment Woman 's age &gt; 18 year â‰¤ 35 year Regular menstrual cycle ( 2534 day ) BMI 18 30 inclusive Signed patient information inform consent form PCOS More 2 prior IVF/ICSI attempt Diabetes mellitus , epilepsy , lever , kidney , heart metabolism disorder , accord Investigator 's assessment .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>COS</keyword>
	<keyword>ART</keyword>
	<keyword>Infertility</keyword>
</DOC>